|
CA2153987A1
(en)
|
1993-01-14 |
1994-07-21 |
U. Prasad Kari |
Amino acids and peptides having modified terminals
|
|
US5654451B1
(en)
|
1993-01-14 |
2000-02-22 |
Magainin Pharma |
Amino acids and peptides having modified c-terminals and modified n-terminals
|
|
EP1532118A2
(en)
|
2002-07-05 |
2005-05-25 |
Axxima Pharmaceuticals Aktiengesellschaft |
Imidazole compounds for the treatment of hepatitis c virus infections
|
|
US20050069522A1
(en)
|
2002-08-12 |
2005-03-31 |
Richard Colonno |
Combination pharmaceutical agents as inhibitors of HCV replication
|
|
DE102004036971B4
(de)
|
2004-07-30 |
2009-07-30 |
Advanced Micro Devices, Inc., Sunnyvale |
Technik zur Bewertung lokaler elektrischer Eigenschaften in Halbleiterbauelementen
|
|
WO2006022442A1
(ja)
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
GB2438802A
(en)
|
2005-02-28 |
2007-12-05 |
Univ Rockefeller |
Structure of the hepatitis C virus NS5A protein
|
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
|
RS51470B
(sr)
|
2005-09-16 |
2011-04-30 |
Arrow Therapeutics Limited |
Derivati bifenila i njihova upotreba za lečenje hepatitisa c
|
|
WO2007058384A1
(en)
|
2005-11-17 |
2007-05-24 |
Osaka University |
Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same
|
|
AU2006330924B2
(en)
|
2005-12-21 |
2012-03-15 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2007081517A2
(en)
|
2005-12-21 |
2007-07-19 |
Abbott Laboratories |
Anti-viral compounds
|
|
SG133452A1
(en)
|
2005-12-30 |
2007-07-30 |
Novartis Ag |
Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases
|
|
KR20090012345A
(ko)
|
2006-05-30 |
2009-02-03 |
애로우 쎄라퓨틱스 리미티드 |
바이페닐 유도체, 및 c형 간염 치료에 있어서의 이들의 용도
|
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7745636B2
(en)
|
2006-08-11 |
2010-06-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20100158862A1
(en)
|
2006-08-11 |
2010-06-24 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN101558059B
(zh)
*
|
2006-08-11 |
2014-12-03 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
|
EP2097405A2
(en)
|
2006-11-21 |
2009-09-09 |
Smithkline Beecham Corporation |
Anti-viral compounds
|
|
TWI399380B
(zh)
|
2006-12-20 |
2013-06-21 |
Abbott Lab |
抗病毒化合物
|
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
|
US8629171B2
(en)
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
|
EP2242751B1
(en)
|
2008-02-12 |
2015-07-15 |
Bristol-Myers Squibb Company |
Heterocyclic derivatives as hepatitis c virus inhibitors
|
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
|
EA024853B1
(ru)
|
2008-12-03 |
2016-10-31 |
Пресидио Фармасьютикалс, Инк. |
Ингибиторы ns5a вгс
|
|
CA2750577A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
CN102264737A
(zh)
|
2008-12-23 |
2011-11-30 |
雅培制药有限公司 |
抗病毒化合物
|
|
WO2010091413A1
(en)
|
2009-02-09 |
2010-08-12 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
|
UY32462A
(es)
|
2009-02-23 |
2010-09-30 |
Arrow Therapeutics Ltd |
Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
|
|
WO2010096777A1
(en)
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
MY160130A
(en)
|
2009-02-27 |
2017-02-28 |
Enanta Pharm Inc |
Hepatitis c virus inhibitors
|
|
EA201190224A1
(ru)
|
2009-03-27 |
2012-03-30 |
Пресидио Фармасьютикалс, Инк. |
Ингибиторы гепатита c, содержащие конденсированные кольца
|
|
EP2410841A4
(en)
|
2009-03-27 |
2012-10-24 |
Presidio Pharmaceuticals Inc |
SUBSTITUTED BICYCLIC HCV INHIBITORS
|
|
MX2011010084A
(es)
|
2009-03-27 |
2011-10-14 |
Merck Sharp & Dohme |
Inhibidores de la replicacion del virus de la hepatitis c.
|
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
TWI476190B
(zh)
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
US20110237636A1
(en)
|
2009-03-30 |
2011-09-29 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
EP2419404B1
(en)
|
2009-04-15 |
2015-11-04 |
AbbVie Inc. |
Anti-viral compounds
|
|
CN102414199B
(zh)
|
2009-04-24 |
2014-03-05 |
泰博特克药品公司 |
二芳基醚
|
|
AU2010249080A1
(en)
|
2009-05-12 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
|
TW202042807A
(zh)
|
2009-05-13 |
2020-12-01 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物
|
|
WO2010138791A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
AU2010253790A1
(en)
|
2009-05-29 |
2011-12-15 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as Hepatitis C
|
|
EP2337781B1
(en)
|
2009-06-11 |
2014-07-23 |
AbbVie Bahamas Ltd. |
Anti-viral compounds to treat hcv infection
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
|
AU2010274001A1
(en)
|
2009-07-16 |
2012-02-23 |
Vertex Pharmaceuticals Incorporated |
Benzimidazole analogues for the treatment or prevention of Flavivirus infections
|
|
CN102471323A
(zh)
|
2009-08-07 |
2012-05-23 |
泰博特克药品公司 |
苯基乙炔基衍生物作为丙型肝炎病毒抑制剂
|
|
BR112012002662A2
(pt)
|
2009-08-07 |
2016-03-22 |
Tibotec Pharm Ltd |
derivados de bis-benzimidazol
|
|
EP2473503B1
(en)
|
2009-09-03 |
2014-07-23 |
Janssen R&D Ireland |
Bis-benzimidazole derivatives
|
|
PE20120993A1
(es)
|
2009-09-04 |
2012-08-22 |
Janssen Pharmaceuticals Inc |
Derivados bifenilicos como antivirales
|
|
WO2011031934A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
EP2475256A4
(en)
|
2009-09-11 |
2013-06-05 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US8415374B2
(en)
|
2009-10-12 |
2013-04-09 |
Bristol-Myers Squibb Company |
Combinations of hepatitis C virus inhibitors
|
|
WO2011050146A1
(en)
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
|
US20110274648A1
(en)
*
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110269956A1
(en)
*
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110281910A1
(en)
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
CA2782024A1
(en)
|
2009-11-25 |
2011-06-03 |
Schering Corporation |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
|
EP2507232B1
(en)
|
2009-12-04 |
2019-03-20 |
National Health Research Institutes |
Proline derivatives
|
|
US8653070B2
(en)
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8377980B2
(en)
*
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN104530079B
(zh)
|
2009-12-18 |
2017-10-20 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
|
AU2010330862B2
(en)
|
2009-12-18 |
2015-06-25 |
Idenix Pharmaceuticals, Inc. |
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
|
|
EP2516430B1
(en)
|
2009-12-22 |
2014-11-05 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
EP2515902A1
(en)
|
2009-12-24 |
2012-10-31 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
US8362020B2
(en)
*
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2011091446A1
(en)
|
2010-01-22 |
2011-07-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
EA201201031A1
(ru)
|
2010-01-25 |
2013-02-28 |
Энанта Фармасьютиклз, Инк. |
Ингибиторы вируса гепатита с
|
|
JP2013518062A
(ja)
|
2010-01-28 |
2013-05-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
C型肝炎阻害化合物
|
|
US8623814B2
(en)
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
US8178531B2
(en)
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
BR112012022311A2
(pt)
|
2010-03-04 |
2016-08-23 |
Enanta Pharm Inc |
agentes farmacêuticos de combinação como inibidores da replicação de hcv.
|
|
WO2011112429A1
(en)
|
2010-03-09 |
2011-09-15 |
Schering Corporation |
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
|
|
JP2013522377A
(ja)
|
2010-03-24 |
2013-06-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス感染を処置または予防するためのアナログ
|
|
EP2550268A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
AU2011232331A1
(en)
|
2010-03-24 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of Flavivirus infections
|
|
WO2011127350A1
(en)
|
2010-04-09 |
2011-10-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
CA2800509A1
(en)
|
2010-05-24 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
WO2011150243A1
(en)
|
2010-05-28 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
EP2575819A4
(en)
*
|
2010-06-04 |
2013-11-27 |
Enanta Pharm Inc |
INHIBITORS OF HEPATITIS C VIRUS
|
|
TW201201801A
(en)
|
2010-06-09 |
2012-01-16 |
Presidio Pharmaceuticals Inc |
Inhibitors of HCV NS5A protein
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
WO2011154871A1
(en)
|
2010-06-10 |
2011-12-15 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
|
WO2012003642A1
(en)
|
2010-07-09 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and use thereof for treating viral diseases
|
|
ES2504977T3
(es)
|
2010-07-26 |
2014-10-09 |
Janssen R&D Ireland |
Derivados hetero-bicíclicos como inhibidores del VHC
|
|
EP2598149A4
(en)
|
2010-07-26 |
2014-09-10 |
Merck Sharp & Dohme |
SUBSTITUTED BIPHENYLENE COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF VIRUS DISEASES
|
|
AU2010358561B2
(en)
|
2010-08-04 |
2016-06-02 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20120196794A1
(en)
|
2010-08-06 |
2012-08-02 |
Bristol-Myers Squibb Company |
Combinations of Hepatitis C Virus Inhibitors
|
|
EP2603080A4
(en)
|
2010-08-12 |
2014-01-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US20120195857A1
(en)
*
|
2010-08-12 |
2012-08-02 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
AR082619A1
(es)
|
2010-08-13 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores del virus de la hepatitis c
|
|
CA2809261A1
(en)
|
2010-08-26 |
2012-03-01 |
Rfs Pharma, Llc |
Potent and selective inhibitors of hepatitis c virus
|
|
WO2012040389A2
(en)
|
2010-09-22 |
2012-03-29 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic hcv inhibitors
|
|
WO2012050918A2
(en)
|
2010-09-29 |
2012-04-19 |
Presidio Pharmaceutical, Inc. |
Tricyclic fused ring inhibitors of hepatitis c
|
|
WO2012040923A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Tetracyclic indole derivatives and methods of use thereof for the treatment of viral diseases
|
|
CA2812779A1
(en)
|
2010-09-29 |
2012-04-19 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
|
JP2013538831A
(ja)
|
2010-09-29 |
2013-10-17 |
メルク・シャープ・エンド・ドーム・コーポレイション |
C型肝炎ウィルス感染治療のための四環式インドール誘導体
|
|
WO2012040924A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocycle compounds and methods of use thereof for treatment of viral diseases
|
|
EP2621932A4
(en)
|
2010-09-29 |
2014-03-26 |
Merck Sharp & Dohme |
TETRACYCLIC HETEROCYCLUS COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS
|
|
EP2621501A4
(en)
|
2010-09-29 |
2014-04-09 |
Merck Sharp & Dohme |
POLYCYCLIC HETEROCYCLUS DERIVATIVES AND METHOD FOR THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
|
|
WO2012048421A1
(en)
|
2010-10-14 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
|
EP2635571B1
(en)
|
2010-11-04 |
2015-08-12 |
Theravance Biopharma R&D IP, LLC |
Novel inhibitors of hepatitis c virus
|
|
EP2640719B1
(en)
|
2010-11-17 |
2017-05-10 |
Gilead Pharmasset LLC |
Antiviral compounds
|
|
RU2452735C1
(ru)
|
2010-11-30 |
2012-06-10 |
Александр Васильевич Иващенко |
Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения
|
|
US20140364616A1
(en)
|
2010-12-15 |
2014-12-11 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2012083053A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2012083059A1
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2651925A4
(en)
|
2010-12-15 |
2014-06-18 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
|
WO2012083061A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2651920A4
(en)
|
2010-12-15 |
2014-12-17 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
|
CA2821973A1
(en)
|
2010-12-16 |
2012-06-21 |
Abbvie Inc. |
Anti-viral compounds
|
|
CA2819894A1
(en)
|
2010-12-16 |
2012-06-21 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2012087976A2
(en)
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
|
WO2012122716A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
|
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
|
US9546160B2
(en)
|
2011-05-12 |
2017-01-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2012162580A2
(en)
|
2011-05-26 |
2012-11-29 |
Abbvie Inc |
Anti-viral compounds
|
|
WO2012162578A2
(en)
|
2011-05-26 |
2012-11-29 |
Abbvie Inc. |
Anti-viral compounds
|
|
PT2714036T
(pt)
|
2011-05-27 |
2016-09-29 |
Achillion Pharmaceuticals Inc |
Alifanos, ciclofanos, heterafanos, heterofanos, heteroheterafanos e metalocenos substituídos úteis no tratamento de infeções hcv
|
|
WO2012175581A1
(en)
|
2011-06-24 |
2012-12-27 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
|
CN102863428B
(zh)
|
2011-07-09 |
2014-12-24 |
广东东阳光药业有限公司 |
作为丙型肝炎病毒抑制剂的螺环化合物
|
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|